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Abstract
 
Immunoglobulin (Ig)E-mediated activation of mast cells has long been thought to occur only
when Fc
 
 
 
RI receptor-bound IgE is cross-linked via multivalent antigens. However, recent
studies have raised the possibility that mast cells may be activated by the binding of IgE to the
Fc
 
 
 
RI receptor in the absence of antigen. Here we demonstrate that IgE binding without anti-
gen induces the expression of histidine decarboxylase (HDC) in mouse interleukin (IL)-3–
dependent bone marrow–derived mast cells (BMMCs). The induction of HDC by the binding
of IgE was found to require an influx of extracellular calcium ions, which was attenuated by
pretreatment with U73122, a phospholipase C inhibitor. Furthermore, the increase in HDC
activity upon sensitization with IgE was completely suppressed by pretreatment of BMMCs
with protein kinase C inhibitors, such as H7, staurosporine, and Gö6976. In addition, immedi-
ate activation of the tyrosine kinase Lyn was not detectable upon treatment with IgE. These re-
sults suggest that the binding of IgE to its receptor in the absence of antigen results in de novo
synthesis of HDC in BMMCs through a signaling pathway distinct to that operating during an-
tigen-stimulated Fc
 
 
 
RI activation.
Key words: histidine decarboxylase • enzyme induction • protein kinase C • calcium signaling • 
IgE receptors
 
Introduction
 
Mast cells are found in various tissues throughout the body
and trigger allergic and inflammatory responses by releasing
a wide variety of mediators, such as histamine, arachidonic
acid metabolites, and neutral proteases (1, 2). Activation
and signaling of Fc
 
 
 
RI, the high-affinity receptor for IgE,
has long been thought to occur only when receptor-bound
IgE is cross-linked via multivalent antigens (1–4). How-
ever, recently reported evidence has raised the possibility
that higher concentrations of IgE can trigger a number of
signaling pathways in mast cells and circulating basophils,
even in the absence of antigens. Treatment of cells with IgE
in the absence of antigen was found to enhance the ex-
pression of Fc
 
 
 
RI by various mast cell populations in vitro
and in mouse peritoneal cells in vivo (5–8). It has been
demonstrated that IL-3–dependent
 
 
 
bone marrow–derived
 
mast cells (BMMCs)
 
*
 
 respond with an increase in cytosolic
Ca
 
2
 
 
 
 levels when treated with IgE alone (9) and that mo-
nomeric IgE stimulates multiple phosphorylation events in
mouse BMMCs, leading to potent cytokine production and
enhanced survival (10, 11). These observations suggest that
monomeric IgE is involved in the activation of mast cells,
which is distinct from induction via antigen stimulation.
The above studies have indicated that monomeric IgE in
the absence of antigen may not be able to stimulate the de-
granulation and release of histamine from mast cells. How-
ever, the regulation of histamine synthesis by monomeric
 
IgE remains to be clarified. We previously purified 
 
l
 
-histi-
dine decarboxylase (HDC), the rate-limiting enzyme of
histamine synthesis in mammals, cloned its cDNA from a
mouse mastocytoma cell line, and prepared a specific anti-
body for HDC, in order to elucidate the mechanism regu-
lating histamine synthesis (12, 13). As previous reports have
demonstrated that atopic patients, who possess extremely
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l
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PKC, protein kinase C; TPA, 12-
 
O
 
-tetradecanoyl phorbol 13-acetate. 
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high concentrations of serum IgE, show higher serum his-
tamine concentrations than normal individuals (14, 15), we
hypothesized that monomeric IgE may be involved in the
up-regulation of HDC. The purpose of our present study
was to investigate the effects of monomeric IgE on hista-
mine synthesis and to identify the signaling pathway in-
volved in this histamine synthesis.
 
Materials and Methods
 
Mice.
 
Specific pathogen-free, 8-wk-old female Balb/c mice
were obtained from Japan SLC.
 
Materials.
 
The anti-HDC antibody was prepared as described
previously (16). The following materials were commercially ob-
tained from the sources indicated: an anti-DNP mouse monoclo-
nal IgE (SPE-7) and DNP-conjugated human serum albumin
from Sigma-Aldrich, an anti-DNP IgG (HDP-1) from Oxford
Biomedical Research, an anti-trinitrophenyl IgE and an anti–
mouse Fc
 
 
 
RIIB/III (2.4G2) antibody from BD Biosciences,
mouse whole IgG molecule from CHEMICON International
Inc. [
 
 
 
-
 
32
 
P]dCTP (3,000 Ci/mmol), and [
 
 
 
-
 
32
 
P]ATP (3,000 Ci/
mmol) from Du Pont-New England Nuclear, a horseradish per-
oxidase–conjugated anti–rabbit IgG antibody from Dako, an ECL
kit from Amersham Biosciences, Fura-2/AM from Dojindo Lab-
oratories, an agarose-conjugated anti-Lyn antibody, and an anti-
Lyn mouse monoclonal antibody from Santa Cruz Biotechnol-
ogy, Inc. All other chemicals were commercial products of re-
agent grade.
 
Preparation of BMMCs.
 
BMMCs were prepared as described
previously with minor modifications (17). Cells were cultured in
the complete RPMI containing 50% WEHI-3–conditioned me-
dium as a source of IL-3 and 10% fetal bovine serum at 37
 
 
 
C in a
fully humidified 5% CO
 
2
 
 atmosphere. After 4 wk of culture,
 
 
 
95% of the viable cells were confirmed to be immature mast
cells, as assessed by staining with acidic Toluidine blue. A linear
increase in the surface expression of Fc
 
 
 
RI was observed upon
flow cytometric analyses in the presence of 3 
 
 
 
g/ml anti-DNP
IgE (data not shown), which is consistent with previous studies
(7, 8).
 
HDC Assay.
 
Cells were rinsed with PBS followed by centrif-
ugation and the cell pellet was lysed (10
 
7
 
 cells/ml) with 10 mM
HEPES–NaOH, pH 7.3, containing 1.5 mM MgCl
 
2
 
, 10 mM
KCl, 0.5 mM dithiothreitol, 1 mM EDTA, 1 mM EGTA, 1%
Triton X-100, and a protease inhibitor mixture (0.2 mM PMSF,
10 
 
 
 
g/ml aprotinin, 10 
 
 
 
g/ml leupeptin, 0.1 mM benzamidine,
1 
 
 
 
g/ml pepstatin A, and 10 
 
 
 
g/ml E-64) on ice for 30 min. The
cells were centrifuged at 100,000 
 
g
 
 for 1 h at 4
 
 
 
C and the super-
natant was used for the measurement of HDC activity as de-
scribed previously (18).
 
Northern Blot Analyses.
 
Total RNA was extracted from cells
using ISOGEN (Nippon Gene), according to the manufacturer’s
instructions. Total RNA (3 
 
 
 
g) obtained was electrophoretically
separated on a 1.5% agarose/formaldehyde gel. After electro-
phoresis, the RNA was transferred onto a Biodyne A membrane
(Pall) in 20
 
 
 
 SSC (1
 
 
 
 SSC is composed of 0.15 M NaCl and
0.015 M sodium citrate) by capillary blotting. [
 
32
 
P]-Labeled spe-
cific cDNA probes were synthesized in the presence of [
 
 
 
-
 
32
 
P]dCTP and hybridized onto the filter in hybridizing solution
(6
 
 
 
 SSC, 5
 
 
 
 Denhardt’s solution, 0.5% SDS, and 100 
 
 
 
g/ml
salmon sperm DNA) at 68
 
 
 
C overnight. The filter was rinsed
twice in 2
 
 
 
 SSC at room temperature and twice in 2
 
 
 
 SSC con-
 
taining 1% SDS at 60
 
 
 
C. The filter was then analyzed using a
Fujix BAS 2000 Bio-Imaging Analyzer.
 
Immunoblot Analyses.
 
Cells were homogenized in 50 mM
HEPES–NaOH, pH 7.3, containing 1 mM dithiothreitol, 1%
Triton X-100, and the protease inhibitor mixture, and centri-
fuged at 15,000 
 
g
 
 for 30 min at 4
 
 
 
C. The resultant supernatant
(50 
 
 
 
g protein/lane) was subjected to SDS-PAGE (10% slab gel),
and the separated proteins were transferred electrophoretically
onto a PVDF membrane (Millipore). Immunoblot analysis was
performed as described previously (18). An anti-HDC antibody
(1:500) was used as the primary antibody, and a horseradish per-
oxidase–conjugated anti–rabbit IgG antibody (1:3,000) was used
as the secondary antibody. The membranes were stained using an
ECL kit according to the manufacturer’s instructions.
 
Cell Culture Under Ca
 
2
 
 
 
-free Conditions.
 
Cells were washed
twice in PIPES buffer (25 mM PIPES, pH 7.4, containing 125
mM NaCl, 2.7 mM KCl, 5.6 mM glucose, 1 mM CaCl
 
2
 
, and
0.1% bovine serum albumin), or in Ca
 
2
 
 
 
-free PIPES buffer. The
cells were then incubated in buffer with or without Ca
 
2
 
 
 
 in the
presence or absence of 3 
 
 
 
g/ml IgE for 90 min at 37
 
 
 
C. The cells
were harvested and Northern blot analyses were performed as de-
scribed above.
 
Measurement of Cytosolic Ca
 
2
 
 
 
 Concentrations.
 
Cells were
loaded with 2 
 
 
 
M Fura-2/AM in modified Tyrode’s buffer (130
mM NaCl containing 5 mM KCl, 1.4 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
,
5.6 mM glucose, 10 mM HEPES, NaOH, pH 7.3, and 0.1% bo-
vine serum albumin) for 45 min at room temperature and then
washed in modified Tyrode’s buffer. For Ca
 
2
 
 
 
 free conditions,
the buffer was replaced with Ca
 
2
 
 
 
 free modified Tyrode’s buffer
containing 0.3 mM EGTA. Fluorescent intensities were mea-
sured, at an excitation wavelength of 340 or 380 nm and an emis-
sion wavelength of 510 nm, with a fluorescence spectrometer
(CAF-100; Jasco) as described previously (19).
 
Treatment with Various Kinase Inhibitors.
 
BMMCs were
treated for the indicated periods with various kinase inhibitors at
the concentrations indicated, before the addition of IgE. Protein
kinase C (PKC) inhibitors: Staurosporine (10 min, 1 
 
 
 
M), H7
(30 min, 0.1 mM), chelerythrine chloride (60 min, 10 
 
 
 
M),
Gö6976 (60 min, 10 
 
 
 
M), PKC inhibitors 19–27, myristoylated
peptide (60 min, 0.1 mM), Ro-32–0432 (60 min, 1 
 
 
 
M), and
bisindolylmaleimide (25 min, 1 
 
 
 
M); tyrosine kinase inhibitors:
herbimycin A (30 min, 1.5 
 
 
 
M), genistein (30 min, 0.1 mM),
PP2 (10 min, 10 
 
 
 
M), and PP3, an inactive analogue of PP2 (10
min, 10 
 
 
 
M); other inhibitors: H89 (protein kinase a [PKA], 30
min, 10 
 
 
 
M), PD98059 (mitogen-activated protein kinase
[MAPK]/ERK kinase [MEK], 30 min, 50 
 
 
 
M), SB203580 (p38,
30 min, 10 
 
 
 
M), LY294002 (phosphoinositide 3
 
 [
 
PI3]-kinase, 30
min, 50 
 
 
 
M), wortmannin (PI3-kinase, 15 min, 0.1 
 
 
 
M), and
W7 (calmodulin, 30 min, 10 
 
 
 
M).
 
Immunoprecipitation and In Vitro Kinase Assay for Lyn.
 
Cells
were incubated in the presence or absence of 3 
 
 
 
g/ml anti-DNP
IgE for 5 min. In the experiment of antigen stimulation, cells
were incubated with 1 
 
 
 
g/ml anti-DNP IgE for 12 h and then
stimulated by the addition of antigens (30, 100, and 300 ng/ml
DNP-human serum albumin) for 5 min. Immunoprecipitation
with an agarose-conjugated anti-Lyn antibody (20 
 
 
 
g/ml) was
performed as described previously (18) in the presence of 1 mM
sodium vanadate. The resultant precipitate was washed four times
with the RIPA buffer followed by two times of washing with 20
mM HEPES-NaOH, pH 8.0, containing 150 mM NaCl, 10 mM
magnesium acetate, and 20 mM MnCl
 
2
 
 (kinase assay buffer). The
precipitate was incubated in kinase assay buffer containing 10 
 
 
 
M
ATP in the presence of 10 
 
 
 
Ci [
 
 
 
-
 
32
 
P]ATP for 5 min at 30
 
 
 
C. 
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Immunoblot analyses were also performed as described above us-
ing an anti-Lyn mouse monoclonal antibody (1:200) to confirm
an equal amount of precipitated Lyn.
 
Results
 
Induction of Histamine Synthesis by IgE in the Absence of An-
tigen.
 
We found significant increases in the HDC activity
of BMMCs upon sensitization with IgE. Among the vari-
ous types of IgG and IgE, only anti-DNP IgE drastically in-
duced HDC activity in BMMCs in the absence of antigen
6 h after stimulation (Table I). Both the anti-DNP IgG and
the polyclonal IgG mixture were unable to increase the
HDC activity of BMMCs. IgE has been shown to bind to
the Fc receptors for IgG (Fc
 
 
 
RII and Fc
 
 
 
RIII), in addition
to Fc
 
 
 
RI in mouse BMMCs (20), and IgE-mediated sys-
temic anaphylaxis has been shown to be enhanced in Fc-
 
 
 
RII-deficient mice whereas being attenuated in Fc
 
 
 
RIII-
deficient mice (21). Blockage of these Fc
 
 
 
Rs with the
2.4G2 antibody has no effect on the increase in HDC ac-
tivity induced by IgE. The HDC activity of BMMCs in-
creased dose dependently by anti-DNP IgE treatment, and
plateau levels were reached at 
 
 
 
3 
 
 
 
g/ml anti-DNP IgE
(data not shown). Northern blot analyses revealed that this
induction occurs in the transcriptional level and a 
 
 
 
10-fold
increase was observed by the addition of 3 
 
 
 
g/ml anti-
DNP IgE (Fig. 1 B). This induction of HDC in BMMCs
was found to be transient. A significant increase in the
HDC activity was first observed 2 h after the addition of
anti-DNP IgE, and a maximal level of HDC activity was
obtained 6 h after the addition of anti-DNP IgE (Fig. 1 A).
A significant increase in HDC mRNA expression was ob-
served 1 h after stimulation with anti-DNP IgE (Fig. 1 B).
Cellular histamine content significantly increased at a later
phase (12 h) with an approximately fourfold increase in his-
tamine content being detected 24 h after the addition of
anti-DNP IgE (Fig. 1 A). Immunoblot analyses using an
anti-HDC antibody revealed that the dominant form of
HDC induced in the BMMCs was the 74-kD form (Fig. 1
C). The 53-kD form of HDC, which we previously re-
ported to be found in a rat mast cell line (18), was hardly
detectable in the BMMCs both in the presence and absence
of anti-DNP IgE (Fig. 1 C).
Figure 1. Time course of HDC activity and
mRNA accumulation induced by IgE. BMMCs
were cultured in the presence of 3  g/ml anti-
DNP IgE for the periods indicated. (A) HDC ac-
tivity (closed boxes) and histamine content (open
boxes) of the cells are demonstrated. The values are
represented as the means   SEM (n     3). (B)
Transient increase in HDC mRNA accumulation is
represented. The relative intensities of the bands
hybridized with the probe for HDC were normal-
ized by those with the probe for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). This is a rep-
resentative figure of three independent experiments
showing similar results. (C) The result of immuno-
blot analyses using an anti-HDC antibody is dem-
onstrated. The arrows indicate the position of the
74-kD form (74-kD) and 53-kD form (53-kD) of
HDC. Note that the 53-kD form is undetectable.
 
Table I.
 
Increase in HDC Activity Induced by IgE or Various 
Activators of the Ca
 
2
 
 
 
–PKC Pathway
 
HDC activity
 
pmol/min/mg protein
 
None 3.13   1.68
Anti-DNP IgE 652   54.8a
Anti-DNP IgG 5.80   1.95
Polyclonal IgG 1.43   1.00
Anti-DNP IgE   2.4G2 626   46.2a
IgE/antigen 389   10.3a, b
Thapsigargin 618   162a
TPA 96.3   23.3a
A23187 1,240   118a
BMMCs were cultured in the presence of an anti-DNP IgE (3  g/ml),
an anti-DNP IgG (3  g/ml), purified polyclonal IgG (3  g/ml),
thapsigargin (100 nM), TPA (10 nM), and A23187 (0.3  M) for 6 h at
37 C. Blocking of Fc RII and Fc RIII was performed by pretreatment
with the 2.4G2 antibody (10  g/ml) for 10 min. In the experiment of
antigen stimulation (IgE/antigen), BMMCs were incubated in the
presence of 1  g/ml anti-DNP IgE for 24 h at 37 C, washed, and then
incubated with 30 ng/ml DNP-human serum albumin for 6 h. The
concentration of each reagent was optimized in preliminary experiments
to obtain its maximal effect. The values obtained are represented as the
means   SEM (n   3).
aP   0.01 is regarded as significant by the Student’s t test (vs. None).
bP   0.05 is regarded as significant by the Student’s t test (vs. Anti-
DNP IgE).232 Histamine Synthesis Induced by Monomeric IgE in Mast Cells
Requirement of Extracellular Ca2  Influx for the Induction of
HDC mRNA. As monomeric IgE has been found to
increase cytoplasmic Ca2  levels in BMMCs (9), the ef-
fect of extracellular Ca2  on the induction of HDC
mRNA by anti-DNP IgE was investigated. Induction of
HDC mRNA by anti-DNP IgE was completely sup-
pressed by the depletion of extracellular Ca2  (Fig. 2 A).
The addition of anti-DNP IgE caused an increase in cy-
tosolic Ca2 , which was completely suppressed by
pretreatment with a phospholipase c (PLC) inhibitor,
U73122 (Fig. 2 B). The increase in cytosolic Ca2  in-
duced by anti-DNP IgE was sustained for a longer pe-
riod compared with that induced by antigen stimulation.
U73343, an inactive analogue of U73122, was unable to
suppress the increase in cytosolic Ca2  induced by both
the addition of anti-DNP-IgE and antigen stimulation.
A slight increase in cytoplasmic Ca2  by anti-DNP IgE
was also observed in the absence of extracellular Ca2 ,
which was also attenuated by pretreatment with U73122
(Fig. 2 C).
Effects of 12-O-Tetradecanoyl Phorbol 13-Acetate, Thapsigar-
gin, and A23187 on the Induction of HDC. The effects of
various activators of the Ca2 -PKC pathway on the induc-
tion of HDC activity were investigated. A phorbol ester,
12-O-tetradecanoyl phorbol 13-acetate (TPA), which is
known to be an activator of PKC, slightly but significantly
induced HDC activity in the BMMCs, whereas thapsigar-
gin, an inhibitor of the Ca2 -ATPase in the endoplasmic
reticulum, and A23187, a calcium ionophore, drastically
increased HDC activity in the BMMCs, to levels compara-
ble to those induced by anti-DNP IgE (Table I). Cross-
linking of the Fc RI with multivalent antigens also caused
the induction of HDC, and this inducible effect was
smaller than that induced by IgE alone (Table I). The ac-
cumulation of HDC mRNA in the cells activated by anti-
gen stimulation was also observed but was smaller than that
observed in cells treated with anti-DNP IgE alone (data
not shown).
Effects of Various Kinase Inhibitors on HDC Expression In-
duced by IgE. The effects of an array of kinase inhibitors
on the induction of HDC were investigated. PKC inhibi-
tors, such as staurosporine, H7, and Gö6976, significantly
suppressed the increase of HDC activity and mRNA ex-
pression whereas the other PKC inhibitors did not (Fig. 3,
A and C). Chelerythrine moderately suppressed the in-
crease in HDC activity but not the increase in mRNA ex-
pression. Inhibitors of PKA (H89), MEK (PD98059), p38
(SB203580), calmodulin (W7), and PI3-kinase (LY294002,
and wortmannin) were all ineffective in suppressing the in-
duction of HDC activity (Fig. 3, A and B). The Src family
protein tyrosine kinase inhibitors, herbimycin A and PP2,
had a modest inhibitory effect on the induction of HDC
(Fig. 3, A and D). All the other inhibitors tested were inef-
fective in inhibiting the induction of HDC.
Absence of Lyn Activation. As the protein tyrosine kinase
Lyn has been found to play critical roles in the early events
induced by the cross-linking of the Fc RI (22), in vitro ki-
nase assay for Lyn was performed in BMMCs. A significant
increase in [32P] incorporation was observed in the bands,
of which molecular mass was 53 and 56 kD, concentration
dependently by antigen stimulation, whereas no changes
were seen upon treatment with anti-DNP IgE alone (Fig.
4). Immunoblot analyses using an anti-Lyn antibody indi-
cated that each immunoprecipitate contained the same
amounts of Lyn.
Discussion
We have demonstrated that IgE is able to induce hista-
mine synthesis in mouse BMMCs even in the absence of
antigen. Recent research has clearly demonstrated that mo-
nomeric IgE activates mouse BMMCs exclusively via their
Fc RI (10, 11). We performed this study using the same
commercial IgE preparation (SPE-7; Sigma-Aldrich) as
these previous studies. Stimulation of Fc RII and Fc RIII
by anti-DNP IgG or by polyclonal IgG caused no signifi-
Figure 2. Requirement of extracellular
Ca2  for the induction of HDC by IgE. (A)
BMMCs were incubated in PIPES buffer
with (Ca2 ) or without Ca2  (Ca2 -free)
for 90 min in the presence (black bars) or
absence (white bars) of 3  g/ml anti-DNP
IgE. The cells were then harvested and
Northern blot analyses were performed.
The relative intensities of the hybridized
bands are demonstrated as described in the
legend to Fig. 1. This is a representative fig-
ure of three independent experiments
showing similar results. (B and C) Ca2  in-
flux induced by anti-DNP IgE was com-
pared with that induced by antigen stimula-
tion. BMMCs were loaded with 2  M
Fura-2/AM in modified Tyrode’s buffer in
the presence (B) or absence (C) of Ca2  as
described in Materials and Methods.
U73122 or U73343 (3  M) was added (U) 3 min (C) or 7 min (B) before the stimulation. (Left panels) Stimulation with anti-DNP IgE (10  g/ml)
added to the culture. (Right panels) Stimulation with antigen (Ag, DNP-human serum albumin, 30 ng/ml) after 12 h of sensitization with anti-DNP IgE
(1  g/ml).233 Tanaka et al.
cant changes in HDC activity. Furthermore, blocking of
these Fc Rs by the 2.4G2 antibody did not alter the activa-
tion of HDC by IgE, indicating that Fc RII and Fc RIII
may not be involved in the induction of HDC. Intracellu-
lar histamine content was significantly increased 12 h after
the addition of IgE. As prolonged treatment of BMMC
with monomeric IgE has been reported to enhance the de-
gree of degranulation by antigen stimulation (8), the in-
crease in the amount of stored histamine by monomeric
IgE in our study indicates that prolonged sensitization of
mast cells with IgE may lead to an enhanced release of his-
tamine. Regarding HDC protein expression in BMMCs,
the 74-kD precursor form of HDC was the dominant form
detected. We previously demonstrated that the 74-kD
form of HDC is present in the cytosol as an enzymatically
active form (18) and is degraded via the ubiquitin-protea-
some pathway (23). In BMMCs treated with IgE, the rapid
disappearance of the 74-kD form may be due to its rapid
degradation via the ubiquitin–proteasome system.
Our results showing the lack of an increase in HDC ex-
pression in the absence of extracellular Ca2  indicate that
the induction of HDC requires the influx of extracellular
Ca2 . Indeed, addition of IgE to BMMCs caused a signifi-
cant increase in cytoplasmic Ca2 . Although such a sus-
tained increase of cytosolic Ca2  has previously been re-
ported (9), it has been unclear as to which signaling
pathway is involved in this Ca2  increase. In our experi-
ments, a PLC inhibitor, U73122, completely inhibited the
increase in cytosolic Ca2 , indicating that PLC may be ac-
tivated upon stimulation with IgE even in the absence of
antigen. Although a slight increase in cytoplasmic Ca2  by
IgE was observed in the absence of extracellular Ca2 , it is
likely that the sustained influx of extracellular Ca2  is es-
sential for the induction of HDC by monomeric IgE. Re-
cently, it has been reported that thapsigargin induces HDC
in a mouse macrophage cell line, via the activation of ex-
tracellular signal–regulated kinase (ERK; reference 24). In
this study, we also confirmed that A23187, TPA, and
thapsigargin induce HDC activity in BMMCs. TPA was
able to induce HDC activity, but the degree of induction
was much lower than that induced by IgE. These observa-
tions suggest that the influx of extracellular Ca2  may play
a crucial role in the induction of HDC in addition to acti-
vation of PKC. Evaluation of the effects of various PKC
inhibitors on the induction of HDC by IgE suggests that
this induction may be mediated by Ca2 -dependent PKC,
as Gö6976 has been reported to be a selective inhibitor for
Figure 3. Effects of various kinase inhibi-
tors on the induction of HDC by IgE.
BMMCs were pretreated with various ki-
nase inhibitors as described in Materials and
Methods. The cells were further incubated
in the presence or absence of 3  g/ml anti-
DNP IgE for 3 h (for Northern blot) or 6 h
(for HDC activity). (Top panels) HDC ac-
tivity of the cells is presented. The values
are represented as the means   SEM (n  
3). (Bottom panels) HDC mRNA accumu-
lation in the cells were measured by North-
ern blot analyses. The relative intensities of
the hybridized bands are demonstrated as
described in the legend to Fig. 1. This is a
representative figure of three independent
experiments showing similar results.
Figure 4. Absence of enzymatic activation of Lyn upon treatment with
IgE. Enzymatic activation of Lyn following IgE sensitization was mea-
sured. BMMCs were incubated with anti-DNP IgE (IgE, 3  g/ml) for 5
min. In the experiment of antigen stimulation, cells were sensitized with
anti-DNP IgE (1  g/ml) for 12 h and then incubated with DNP-human
serum albumin (0, 30, 100, 300 ng/ml) for 5 min. In vitro kinase assay us-
ing [ -32P]ATP was performed as described in Materials and Methods.
Immunoblot analyses were also performed using an anti-Lyn antibody
(1:200) to confirm an equal amount of precipitated Lyn. The arrows indi-
cate Lyn tyrosine kinase, which is detected as two bands with molecular
mass of 53 and 56 kD.234 Histamine Synthesis Induced by Monomeric IgE in Mast Cells
Ca2 -dependent PKC isozymes (25). However, as the
other PKC inhibitors, such as bisindolylmaleimide and Ro-
32–0432, were found to be ineffective, we cannot exclude
the possibility that another PKC-like kinase is involved in
the induction of HDC.
IL-6 production induced by monomeric IgE has been
found to be inhibited by a PI-3 kinase inhibitor,
LY294002, a MEK inhibitor, PD98059, and a p38 inhibi-
tor, SB203580 (10). Although we have also observed these
inhibitory effects on the IL-6 production under similar
conditions to the previous report (3  g/ml IgE, 3 h, con-
trol; 5.47   0.634,   LY294002; 0   0,   PD98059; 1.06  
0.164,   SB203580; 1.40   0.193 ng/106 cells, n   6),
HDC induction by IgE was not suppressed by these inhibi-
tors. These results indicate that signaling pathways involved
in the induction of HDC and IL-6 are different, although
both genes are induced by monomeric IgE in BMMCs. In-
duction of histamine synthesis in BMMCs was also found
to be stimulated by antigen stimulation, as well as IL-6 pro-
duction is. It remains to be clarified as to why histamine
synthesis and IL-6 production is induced via IgE both in
the presence and absence of antigen. One possible explana-
tion is that the two pathways of HDC induction may occur
in a different context of mast cell differentiation.
The partial suppression of HDC induction by herbimy-
cin A and by PP2 indicates the involvement of Src family
tyrosine kinases including Lyn, although stimulation with
IgE did not augment the enzymatic activity of Lyn. This
observation suggests that Src family tyrosine kinase other
than Lyn may be involved in the induction of HDC. The
inhibitory effect of a PLC inhibitor, U73122, indicates that
PLC may be involved in the increase in cytosolic Ca2  by
IgE, although the signaling pathway responsible for the ac-
tivation of PLC remains unknown. Further analyses on the
pathways downstream of Fc RI activation, including the
identification of the PKC isozyme activated by monomeric
IgE, should be required.
In summary, we have demonstrated that monomeric IgE
can induce histamine synthesis in BMMCs in the absence
of its antigen. This induction requires the influx of extra-
cellular Ca2  and may be mediated by PKC.
We thank Ms A. Popiel for her help in preparation of the manu-
script.
This study was supported by grants-in-aid for Scientific Re-
search from the Ministry of Education, Science, Sports and Cul-
ture, Japan.
Submitted: 7 December 2001
Revised: 20 May 2002
Accepted: 13 June 2002
References
1. Metcalfe, D.D., D. Baram, and Y.A. Mekori. 1997. Mast
cells. Physiol. Rev. 77:1033–1079.
2. Costa, J.J., P.F. Weller, and S.J. Galli. 1997. The cells of
the allergic response. Mast cells, basophils, and eosinophils.
JAMA. 278:1815–1822.
3. Mekori, Y.A., and D.D. Metcalfe. 2000. Mast cells in innate
immunity. Immunol. Rev. 173:131–140.
4. Kinet, J.-P. 1999. The high-affinity IgE receptor (Fc RI):
from physiology to pathology. Annu. Rev. Immunol. 17:931–
972.
5. Furuichi, K., J. Rivera, and C. Isersky. 1985. The receptor
for immunoglobulin E on rat basophilic leukemia cells: effect
of ligand binding on receptor expression. Proc. Natl. Acad.
Sci. USA. 82:1522–1525.
6. Quarto, R., J.-P. Kinet, and H. Metzger. 1985. Coordinate
synthesis and degradation of the alpha-, beta- and gamma-
subunit of the receptor for immunoglobulin E. Mol. Immunol.
22:1045–1051.
7. Hsu, C., and D. MacGlashan, Jr. 1996. IgE antibody up-reg-
ulates high affinity IgE binding on murine bone marrow de-
rived mast cells. Immunol. Lett. 52:129–134.
8. Yamaguchi, M., C.S. Lantz, H.C. Oettgen, I.M. Katona, T.
Fleming, K. Yano, I. Miyajima, J.-P. Kinet, and S.J. Galli.
1997. IgE enhances mouse mast cell Fc RI expression in
vitro and in vivo: evidence for a novel amplification mecha-
nism in IgE-dependent reactions. J. Exp. Med. 185:663–672.
9. Huber, M., C.D. Helgason, J.E. Damen, L. Liu, R.K.
Humphries, and G. Krystal. 1998. The src homology 2-con-
taining inositol phosphatase (SHIP) is the gatekeeper of mast
cell degranulation. Proc. Natl. Acad. Sci. USA. 95:11330–
11335.
10. Kalesnikoff, J., M. Huber, V. Lam, J.E. Damen, J. Zhang,
R.P. Shiraganian, and G. Krystal. 2001. Monomeric IgE
stimulates signaling pathways in mast cells that lead to cyto-
kine production and cell survival. Immunity. 14:801–811.
11. Asai, K., J. Kitaura, Y. Kawakami, N. Yamagata, M. Tsai,
D.P. Carbone, F. Liu, S.J. Galli, and T. Kawakami. 2001.
Regulation of mast cell survival by IgE. Immunity. 14:791–
800.
12. Ohmori, E., T. Fukui, N. Imanishi, K. Yatsunami, and A.
Ichikawa. 1990. Purification and characterization of L-histi-
dine decarboxylase from mouse mastocytoma P-815 cells. J.
Biochem. 107:834–839.
13. Yamamoto, J., K. Yatsunami, E. Ohmori, Y. Sugimoto, T.
Fukui, T. Katayama, and A. Ichikawa. 1990. cDNA-derived
amino acid sequence of L-histidine decarboxylase from
mouse mastocytoma p-815 cells. FEBS Lett. 276:214–218.
14. Ring, J., T. Senter, R.C. Cornell, C.M. Arroyave, and E.M.
Tan. 1979. Plasma complement and histamine changes in
atopic dermatitis. Br. J. Dermatol. 100:521–530.
15. Ring, J. 1983. Plasma histamine concentrations in atopic ec-
zema. Clin. Allergy. 13:545–552.
16. Asahara, M., S. Musiake, S. Shimada, H. Fukui, Y. Kinoshita,
C. Kawanami, T. Watanabe, S. Tanaka, A. Ichikawa, Y.
Uchiyama, et al. 1996. Reg gene expression is increased in
rat gastric enterochromaffin-like cells following water im-
mersion stress. Gastroenterology. 111:45–55.
17. Rottem, M., J.P. Goff, J.P. Albert, and D.D. Metcalfe. 1993.
The effects of stem cell factor on the ultrastructure of Fc RI 
cells developing in IL-3-dependent murine bone marrow-
derived cell cultures. J. Immunol. 151:4950–4963.
18. Tanaka, S., K. Nemoto, E. Yamamura, and A. Ichikawa.
1998. Intracellular localization of the 74- and 53-kDa forms
of L-histidine decarboxylase in a rat basophilic/mast cell line,
RBL-2H3. J. Biol. Chem. 273:8177–8182.
19. Grynkiewicz, G., M. Penie, and R.Y. Tsien. 1985. A new
generation of Ca2  indicators with greatly improved fluores-
cence properties. J. Biol. Chem. 260:3440–3450.235 Tanaka et al.
20. Takizawa, F., M. Adamczewski, and J.-P. Kinet. 1992. Iden-
tification of the low affinity receptor for immunoglobulin E
on mouse mast cells and macrophages as Fc RII and Fc-
 RIII. J. Exp. Med. 176:469–476.
21. Ujike, A., Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, M.
Fukumoto, J.V. Ravetch, and T. Takai. 1999. Modulation of
immunoglobulin (Ig)E-mediated systemic anaphylaxis by
low-affinity Fc receptors for IgG. J. Exp. Med. 189:1573–
1579.
22. Turner, H., and J.-P. Kinet. 1999. Signaling through the
high-affinity IgE receptor Fc RI. Nature. 402:B24–B30.
23. Tanaka, S., K. Nemoto, E. Yamamura, S. Ohmura, and A.
Ichikawa. 1997. Degradation of the 74 kDa form of L-histi-
dine decarboxylase via the ubiquitin-proteasome pathway in
a rat basophilic/mast cell line (RBL-2H3). FEBS Lett. 417:
203–207.
24. Shiraishi, M., N. Hirasawa, Y. Kobayashi, S. Oikawa, A.
Murakami, and K. Ohuchi. 2000. Participation of mitogen-
activated protein kinase in thapsigargin- and TPA-induced
histamine production in murine macrophage RAW264.7
cells. Br. J. Pharmacol. 129:515–524.
25. Martiny-Baron, G., M.G. Kazanietz, H. Mischak, P.M.
Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schach-
tele. 1993. Selective inhibition of protein kinase C isozymes
by the indolocarbazole Go 6976. J. Biol. Chem. 268:9194–
9197.